The market remained relatively static until 2021 when Novo Nordisks semaglutide (Ozempic for diabetes and Wegovy for obesity) was approved, showing nearly 10% weight loss over two years
A month's supply of Zepbound purchased directly from its maker, Eli Lilly and Company, can still cost $299 to $449, while Ozempic and Wegovy both made by Novo Nordisk carry comparable list prices, and insurance coverage remains spotty
As the curtains closed on Ozempic's unexpected weight loss plot twist, the stage was set for a new star to rise: Wegovy (also semaglutide)
In a suppressed-appetite, moderate-calorie-deficit state, that volume ceiling drops
However, they are not a substitute for professional medical advice, diagnosis, or treatment